mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.9 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |